Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New Evidence
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
In spite of its proven heuristic value, the dopamine hypothesis of schizophrenia is now yielding to a multifactorial view, in which the other monoamines as well as glutamate and GABA are included, with a focus on neurotransmitter interactions in complex neurocircuits. The primary lesion(s) in schizophrenia does not necessarily involve any of these neurotransmitters directly but could deal with a more general defect, such as a faulty connectivity of developmental origin. Nevertheless, a precise identification of neurotransmitter aberrations in schizophrenia will probably provide clues for a better understanding of the disease and for the development of new treatment and prevention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Self-citationLaruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
Carlsson, M., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,082
Self-citationReversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006
The current status of the dopamine hypothesis of schizophrenia
CARLSSON, A. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 958
Self-citationIncreased Striatal Dopamine Transmission in Schizophrenia: Confirmation in a Second Cohort
Abi-Dargham, A., Gil, R., Krystal, J., Baldwin, R. M., Seibyl, J. P., Bowers, M., van Dyck, C. H., Charney, D. S., Innis, R. B., & Laruelle, M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.761 · Cited by 803
Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
Kim, J. S., Kornhuber, H. H., Schmid-Burgk, W., & Holzmüller, B. (1980) · Neuroscience Letters · doi:10.1016/0304-3940(80)90178-0 · Cited by 694
D-Alanine Added to Antipsychotics for the Treatment of Schizophrenia
Tsai, G. E., Yang, P., Chang, Y.-C., & Chong, M.-Y. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.032 · Cited by 674
D-serine added to antipsychotics for the treatment of schizophrenia
Tsai, G., Yang, P., Chung, L.-C., Lange, N., & Coyle, J. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00279-0 · Cited by 571
Emerging principles of altered neural circuitry in schizophrenia
Benes, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00041-7 · Cited by 513
The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
Carlsson, M., & Carlsson, A. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258633 · Cited by 423
Self-citationAbi-Dargham, A., Krystal, J. H., Anjilvel, S., Scanley, B. E., Zoghbi, S., Baldwin, R. M., Rajeevan, N., Ellis, S., Petrakis, I. L., Seibyl, J. P., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1550 · Cited by 405
Marek, G. J., Wright, R. A., Schoepp, D. D., Monn, J. A., & Aghajanian, G. K. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35262-0 · Cited by 280
The role of 5-HT2A receptors in antipsychotic activity
Schmidt, C. J., Sorensen, S. M., Kenne, J. H., Carr, A. A., & Palfreyman, M. G. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00210-w · Cited by 215
Svensson, T. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00048-x · Cited by 205
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
Carlsson, A., Hansson, L. O., Waters, N., & Carlsson, M. L. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00228-2 · Cited by 187
Self-citationHietala, J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020040004 · Cited by 175
Network interactions in schizophrenia — therapeutic implications
Carlsson, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00050-8 · Cited by 174
Self-citationPresynaptic dopaminergic function in the striatum of schizophrenic patients
Dao-Castellana, M.-H., Paillère-Martinot, M.-L., Hantraye, P., Attar-Lévy, D., Rémy, P., Crouzel, C., Artiges, E., Féline, A., Syrota, A., & Martinot, J.-L. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00102-8 · Cited by 160
Miller, D. W., & Abercrombie, E. D. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02144-2 · Cited by 146
Carlsson, M. L., & Svensson, A. I. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90123-y · Cited by 124
Self-citationSystemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats
Martin, P., Carlsson, M. L., & Hjorth, S. (1998) · NeuroReport · doi:10.1097/00001756-199809140-00012 · Cited by 118
Self-citationMuscimol: GABA agonist therapy in schizophrenia
Tamminga, C. A., Crayton, J. W., & Chase, T. N. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.6.746 · Cited by 117
Sonesson, C., Lin, C., Hansson, L. O., Waters, N., Svensson, K., Carlsson, A., Smith, M., & Wikstroem, H. V. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00043a013 · Cited by 113
Self-citationLahti, A. C., Weiler, M. A., Corey, P. K., Lahti, R. A., Carlsson, A., & Tamminga, C. A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00030-9 · Cited by 104
Self-citationAgren, H., Reibring, L., Hartvig, P., Tedroff, J., Bjurling, P., Hörnfeldt, K., Andersson, Y., Lundqvist, H., & Langström, B. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb05574.x · Cited by 96
Self-citationMartin, P., Waters, N., Schmidt, C. J., Carlsson, A., & Carlsson, M. L. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050064 · Cited by 90
Self-citationCarlsson, M. L. (1995) · Journal of Neural Transmission · doi:10.1007/bf01276460 · Cited by 90
Self-citationCarlsson, M. L. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244978 · Cited by 81
Self-citationCarlsson, M. L., Martin, P., Nilsson, M., Sorensen, S. M., Carlsson, A., Waters, N., & Waters, N. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050144 · Cited by 78
Self-citationNew morphological and neuropathological findings in schizophrenia: a neurodevelopmental perspective.
Bunney, B. G., Potkin, S. G., & Bunney, W. E. (1995) · PubMed · Cited by 53
Svensson, A. I., & Carlsson, M. L. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90092-4 · Cited by 50
Self-citationSvensson, K. A., Hjorth, S., Clark, D. T., Carlsson, A., Wikstr�m, H., Andersson, B. A., Sanchez, D., Johansson, A., Arvidsson, L. E., Hacksell, U., et al. (1986) · Journal of Neural Transmission · doi:10.1007/bf01249608 · Cited by 43
Self-citationOn the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801
Martin, P., Svensson, A. I., Carlsson, A., & Carlsson, M. L. (1994) · Journal of Neural Transmission · doi:10.1007/bf01276430 · Cited by 39
Self-citationHansson, L. O., Waters, N., Holm, S., & Sonesson, C. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00016a015 · Cited by 33
Self-citationHansson, L. ‐., Waters, N., Winblad, B. G., Gottfries, C. G., & Carlsson, A. (1994) · Journal of Neural Transmission · doi:10.1007/bf01276538 · Cited by 29
Self-citationWaters, N., Lundgren, C., Hansson, L. ‐., & Carlsson, M. L. (1996) · Journal of Neural Transmission · doi:10.1007/bf01292621 · Cited by 25
Self-citationCarlsson, M. L., & Svensson, A. I. (1990) · Springer eBooks · doi:10.1007/978-94-011-2262-7_56 · Cited by 9
Self-citationLindström, L. H., Gefvert, O., Hagberg, G. E., Hagström, P., Lundberg, T., Bergström, M., Hartvig, P., & Långström, B. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)88535-0 · Cited by 9
Cited by
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Robinson, T. E., & Berridge, K. C. (2003) · Annual Review of Psychology · doi:10.1146/annurev.psych.54.101601.145237 · Cited by 1,509
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
Meyer-Lindenberg, A., Miletich, R. S., Kohn, P. D., Esposito, G., Carson, R. E., Quarantelli, M., Weinberger, D. R., & Berman, K. F. (2002) · Nature Neuroscience · doi:10.1038/nn804 · Cited by 652
“This anatomical account is also consistent with the proposa”
Result
Metadata
- Authors
- Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M., & Carlsson, M. L.
- Venue
- Annual Review of Pharmacology and Toxicology
- Publisher
- Annual Reviews
- Published
- 2001-04
- Volume
- 41
- Issue
- 1
- Pages
- 237-260
- ISSN
- 0362-1642 (ISSN-L)
- 1545-4304
- OpenAlex
- W2099635835
- Cited by
- 688
- References
- 41
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.